Invention Grant
US09125949B2 Direct utilization of plasma proteins for the in vivo assembly of protein-drug/imaging agent conjugates, nanocarriers and coatings for biomaterials
有权
直接利用血浆蛋白质用于生物材料的蛋白质 - 药物/成像剂缀合物，纳米载体和涂层的体内装配
- Patent Title: Direct utilization of plasma proteins for the in vivo assembly of protein-drug/imaging agent conjugates, nanocarriers and coatings for biomaterials
- Patent Title (中): 直接利用血浆蛋白质用于生物材料的蛋白质 - 药物/成像剂缀合物，纳米载体和涂层的体内装配
-
Application No.: US12649941Application Date: 2009-12-30
-
Publication No.: US09125949B2Publication Date: 2015-09-08
- Inventor: Robby A. Petros
- Applicant: Robby A. Petros
- Applicant Address: US TX Denton
- Assignee: University of North Texas
- Current Assignee: University of North Texas
- Current Assignee Address: US TX Denton
- Agency: Chalker Flores, LLP
- Agent Chainey P. Singleton; Edwin S. Flores
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K47/48
Abstract:
The present invention includes compositions and methods for making and using a drug conjugated to a peptide or protein that binds specifically to a ligand in vivo, wherein the conjugate binds to its ligand in vivo and increases the half-life of the drug.
Public/Granted literature
Information query
